CMV prophylaxis: A useful step towards prevention of post-transplant diabetes?

Diabetologia

Volumn 47, Issue 9, 2004, Pages 1473-1475

  Smith, R M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; FINGOLIMOD; GLUCOSE; GLYCOGEN SYNTHASE; HLA ANTIGEN CLASS 1; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN RECEPTOR; LYMPHOCYTE ANTIBODY; MESSENGER RNA; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; INFECTION PREVENTION; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LIFESTYLE; NOTE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DIABETES MELLITUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TACROLIMUS;

EID: 5644266233     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1500-x     Document Type: Note

References (20)

1. Jindal RM, Hjelmesæth J (2000) Impact and management of posttransplant diabetes mellitus. Transplantation 70 [Suppl]:SS58-SS63
2. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 15:89-94
3. Weir MR, Fink JC (1999) Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 34:1-13
4. Ekstrand AV (1991) Effect of steroid-therapy on insulin sensitivity in insulin-dependent diabetic patients after kidney transplantation. J Diabetic Complications 5:244-248
5. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC (1992) Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53:563-569
6. Ekstrand A, Schalin-Jantti C, Lofman M et al. (1996) The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation. Transplantation 61:889-893
7. Kahn CR, Goldfine ID, Neville DM et al. (1978) Alteration in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 103:1054-1066
8. Rizza MA, Mandarino LJ, Gerich JE (1982) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab 54:131-138
9. Ishizuka J, Gugliuzza KK, Wassmuth Z et al. (1993) Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 56:1486-1490
10. Polastri L, Galbiati F, Bertuzzi F et al. (2002) Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol 39:229-233
11. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP (1996) Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 98:2786-2793
12. Robertson RP (1986) Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 35:1016-1019
13. Strasser S, Alejandro R, Shapiro ET, Ricordi C, Todo S, Mintz DH (1992) Effect of FK506 on insulin secretion in normal dogs. Metabolism 41:64-67
14. Ryan EA, Lakey JR, Paty BW et al. (2002) Successful islet transplantation; continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157
15. Shapiro AM, Lakey JR, Ryan EA et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
16. Marchetti P (2001) Strategies for risk reduction and management of posttransplant diabetes mellitus. Transplant Proc 33 [Suppl 5A]:27S-31S
17. Hjelmesæth J, Sagedal S, Hartmann A et al. (2004) Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 47 DOI 10.1007/s00125-004-1499-z
18. EBPG Expert Group on Renal Transplantation (2000) European Best Practice Guidelines for Renal Transplantation (Part 1). Nephrol Dial Transplant 15 [Suppl 7]:71-74
19. Mauskopf JA, Richter A, Annemans L, Maclaine G (2000) Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valacyclovir prophylaxis with current practice. Pharmacoeconomics 18:239-251
20. Das A (2003) Cytomegalovirus infection in solid organ transplantation: economic implications. Pharmacoeconomics 21:467-475